Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

Fig. 3

Association of ANLN expression with survival. In cohort I, high ANLN nuclear fraction was significantly associated with a poor outcome in overall survival (a) and breast cancer specific survival (b) but not in recurrence free survival (c). High ANLN nuclear fraction was significantly correlated to a shorter overall survival (d), breast cancer specific survival (e) and recurrence free survival (f) in cohort II

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us